34 Sands Capital Edwards Lifesciences Trades
Sands Capital's position in Edwards Lifesciences is currently worth $519 Million. That's 1.44% of their equity portfolio (25th largest holding). The investor owns 1.01% of the outstanding Edwards Lifesciences stock. The first Edwards Lifesciences trade was made in Q3 2015. Since then Sands Capital bought shares eight more times and sold shares on 25 occasions. The stake costed the investor $261 Million, netting the investor a gain of 99% so far.
News about Edwards Lifesciences Corp and Sands Capital
Northwest Capital Management Inc Makes New Investment in Edwards Lifesciences Co. (NYSE:EW)
Northwest Capital Management Inc acquired a new position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) during the 2nd quarter, according to i...
Chicago Capital LLC Lowers Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)
Chicago Capital LLC lowered its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 0.6% during the second quarter, HoldingsChannel.com...
Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands
Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA ) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stoc...